Y. Norimine et al. / Tetrahedron: Asymmetry 13 (2002) 1493–1502
1501
version of the substrate, immobilized lipase was
removed by filtration, and the filtrate was concentrated
in vacuo to leave an oily residue, which was purified by
column chromatography on silica gel. The fraction
eluted with 25% EtOAc in hexane afforded the (S)-ace-
tate 3a of 99.15% ee (11.5 g, 87%) and the recovered
(S)-alcohol 4 of 73% ee (1.4 g, 13%) as colorless oils.
cipitated colorless crystals were collected by filtration
and dried in an oven at 60°C for 9 days to give E2050
as colorless crystals (10.77 g, 61%), >99.9% ee, [h]D29
1
−5.2 (c 0.73, EtOH), H NMR (400 MHz, DMSO-d6);
l (ppm) 0.68 (d, J=6.6 Hz, 3H), 1.11 (d, J=6.6 Hz,
3H), 1.22–1.34 (m, 1H), 1.58–1.72 (m, 1H), 2.06–2.30
(m, 3H), 3.00–3.25 (m, 2H), 3.30–3.80 (m, 10H), 4.36
(brs, 2H), 6.98–7.07 (m, 2H), 7.11–7.20 (m, 2H), 7.32–
7.40 (m, 1H), 7.40–7.50 (m, 4H), ESI-Mass; 424 (MH+),
mp 183–187°C. HPLC impurities: 0.68%, residual sol-
vent: 0.09%, water content: 0.30%, chloride ion content:
14.56% (% anhydrous/desolvated theoretical value=
14.28%)).
4.18. (2S)-5-{4-[2-(4-Fluorophenoxy)ethyl]piperazin-1-
yl}-2-isopropyl-2-phenylpentanenitrile dihydrochloride
(E2050)
To a solution of the (S)-acetate 3a of 99.15% ee (11.51
g, 44.5 mmol) in methanol (500 ml) was added K2CO3
(11 g, 79.6 mmol). The mixture was stirred at room
temperature overnight, then neutralized with 5N
aqueous HCl, and concentrated in vacuo to give an oily
residue, to which water was added. The mixture was
extracted with EtOAc. The combined extracts were
dried over Na2SO4. Removal of the solvent in vacuo
gave the (S)-alcohol 4 as a colorless oily residue (9.16
g), which was dissolved in acetonitrile (70 ml). To this
solution, Et3N (12.8 ml, 91.8 mmol) was added. The
mixture was cooled to 0°C, and a solution of methane-
sulfonyl chloride (3.66 ml, 46.3 mmol) in acetonitrile
(70 ml) was added dropwise. The reaction mixture was
stirred at 0°C for 1 h, then at room temperature
overnight, and concentrated in vacuo to give an oily
residue, which was dissolved in ether (300 ml). This
solution was washed with brine. The organic layer was
dried over Na2SO4. Removal of the solvent in vacuo
gave 12.13 g of the mesylate as a dark reddish oil,
which was dissolved in acetonitrile (113 ml). To this
solution, sodium iodide (6.97 g, 46.5 mmol), Et3N (6.4
ml, 45.9 mmol) and p-fluorophenoxyethylpiperazine
(10.41 g, 46.4 mmol) were added. The mixture was
stirred at 70°C for 3 h. The reaction mixture was cooled
to room temperature and concentrated in vacuo to give
an oily residue, which was dissolved in EtOAc (400 ml).
This solution was washed with water (400 ml), and the
organic layer was dried over Na2SO4. Removal of the
solvent in vacuo left an oily residue, which was purified
by column chromatography on Cromatorex NH silica
gel. The fraction eluted with 17% EtOAc in hexane
afforded the free form of E2050 as a colorless oil (15.22
g, 80.2% yield from compound 4). 99.6% ee, [h]2D0 −3.9
A second crop of crystals of E2050 was obtained; 1.19
g (6.7%), 99.05% ee. Filtrate; 2.58 g (14.5%), 99.47% ee.
Acknowledgements
We wish to thank members of the Analytical Chemistry
Section of Eisai Tsukuba Research Laboratories for
interpretation of NMR and mass spectra and for
obtaining elemental analysis data.
References
1. (a) Cox, B.; Denyer, J. C.; Exp. Opin. Ther. Patents., 8,
1237, 1998; (b) Yamamoto, N.; Komatsu, M.; Suzuki, Y.;
Kawano, K.; Kimura, T.; Ito, K.; Nagato, S.; Norimine,
Y.; Niidome, T.; Teramoto, T.; Hatakeyama, S.; Iimura,
Y.; JP 2000–169462; (c) Yamamoto, N.; Suzuki, Y.;
Iimura, Y.; Komatsu, M.; Kawano, K.; Kimura, T.;
Norimine, Y.; Ito, K.; Nagato, S.; Niidome, T.; Teramoto,
T.; Kimura, M.; Kaneda, Y.; Amino, H.; Ueno, M.;
Hamano, T.; Nishizawa, Y.; Yonaga, M. The 20th Sympo-
sium on Medicinal Chemistry/9th Annual Meeting of
Division of Medicinal Chemistry of the Pharmaceutical
Society of Japan (December 6–8, Tokyo) 2000 1P-22; (d)
Niidome, T.; Kimura, M.; Amino, H.; Komatsu, M.;
Yamamoto, N.; Suzuki, Y.; Iimura, Y.; Nishizawa, Y.
Society for Neuroscience 31st Annual Meeting San Diego,
Abstract 332, 14, 2001, Haslam, E. Shikimic Acid
Metabolism and Metabolites; John Wiley & Sons: New
York, 1993; (e) Kaneda, Y.; Teramoto, T.; Hatakeyama,
S.; Ueno, M.; Niidome, T.; Komatsu, M.; Yamamoto, N.;
Suzuki, Y.; Iimura, Y.; Nishizawa, Y.; Society for Neuro-
science 31st Annual Meeting San Diego, Abstract 332, 15,
2001; (f) Yamamoto, N.; Suzuki, Y.; Iimura, Y.; Komatsu,
M.; Kawano, K.; Kimura, T.; Norimine, Y.; Ito, K.;
Nagato, S.; Niidome, T.; Teramoto, T.; Kimura, M.;
Kaneda, Y.; Amino, H.; Ueno, M.; Hamano, T.;
Nisizawa, Y.; Yonaga, M.; presented in part at the 222nd
American Chemical Society National Meeting, Chicago,
August, 2001.
1
(c 1.46, CHCl3), H NMR (400 MHz, CDCl3); l (ppm)
0.77 (d, J=6.8 Hz, 3H), 1.05–1.17 (m, 1H), 1.20 (d,
J=6.8 Hz, 3H), 1.50–1.60 (m, 1H), 1.88 (dt, J=4.4 Hz,
12.4 Hz, 1H), 2.06–2.19 (m, 2H), 2.24–2.30 (m, 2H),
2.30–2.43 (m, 4H), 2.46–2.62 (m, 4H), 2.77 (t, J=5.8
Hz, 2H), 4.04 (t, J=5.8 Hz, 2H), 6.80–6.85 (m, 2H),
6.91–6.99 (m, 2H), 7.25–7.32 (m, 1H), 7.32–7.40 (m,
4H).
4N HCl/EtOAc (18 ml) was added dropwise to a
solution of the free form of E2050 (15.2 g) in EtOAc
(150 ml), and the mixture was stirred at room tempera-
ture for 30 s. After removal of the solvent, the residual
white precipitate was dissolved in 1-propanol (88.5 ml)
under reflux. The solution was stirred while being grad-
ually cooled to room temperature overnight. The pre-
2. (a) Gilmore, J.; Prowse, W.; Steggles, D.; Urquhart, M.;
Olkowski, J. J. Chem. Soc., Perkin Trans. 1 1996, 2845–
2850; (b) Ambler, S. J.; Dell, C. P.; Sanchiz-Suarez, A.;
Simmonds, R. G.; Timms, W. J. EP 0805147.